Many breast-cancer patients receive unnecessary treatment for possible tumour spread after the removal of a primary tumour. Molecular profiling should offer more accurate predictions of who needs such treatment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
BMC Cancer Open Access 29 May 2008
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Golub, T. R. et al. Science 286, 531–537 (1999).
van't Veer, L. J. et al. Nature 415, 530–536 (2002).
Goldhirsch, A., Glick, J. H., Gelber, R. D. & Senn, H.-J. J. Natl Cancer Inst. 90, 1601–1608 (1998).
National Institutes of Health Consensus Development Panel J. Natl Cancer Inst. 93, 979–989 (2001).
McGuire, W. L. J. Natl Cancer Inst. 83, 154–155 (1991).
Alizadeh, A. A. et al. Nature 403, 503–511 (2000).
Bittner, M. et al. Nature 406, 536–540 (2000).
Perou, C. M. et al. Nature 406, 747–752 (2000).
Khan, J. et al. Nature Med. 7, 673–679 (2001).
Aparicio, S. A., Caldas, C. & Ponder, B. Genome Biol. 1, 1021.1–1021.3 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caldas, C., Aparicio, S. The molecular outlook. Nature 415, 484–485 (2002). https://doi.org/10.1038/415484a
Issue Date:
DOI: https://doi.org/10.1038/415484a
This article is cited by
-
A low variance error boosting algorithm
Applied Intelligence (2010)
-
Current potential and limitations of molecular diagnostic methods in head and neck cancer
European Archives of Oto-Rhino-Laryngology (2010)
-
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
BMC Cancer (2008)
-
Prädiktive Biomarker
Der Onkologe (2007)
